← Evidence map

ArticleFrontiers in pharmacology2022

Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy.

Maria Giuseppa Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36425572